TrademarkDir
INTERWOVN
DEAD

Serial Number

88368311

Owner

Cumberland Group, LLC

Attorney

ELIZABETH BURKHARD

Filing Date

Apr 2, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

INTERWOVN Trademark

Serial Number: 88368311

INTERWOVN is a trademark filed by Cumberland Group, LLC on April 2, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Cumberland Group, LLC (4 trademarks)

300 Galleria Parkway, Suite 1600
Atlanta, GA 30339

Entity Type: 16

Trademark Details

Filing Date

April 2, 2019

Registration Date

Not Registered

Published for Opposition

August 6, 2019

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 8, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2020 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 1, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2019 NONP
ASSIGNED TO LIE
Jul 1, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 19, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 19, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 19, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 19, 2019 CNEA
ASSIGNED TO EXAMINER
Jun 12, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2019 NWOS
NEW APPLICATION ENTERED
Apr 5, 2019 NWAP

Related Trademarks

More from this Owner

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT

WHATEVER IT TAKES FOR WHATEVER'S NEXT